Company Progyny, Inc.

Equities

PGNY

US74340E1038

Managed Healthcare

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
32.04 USD -1.42% Intraday chart for Progyny, Inc. -2.02% -13.82%

Business Summary

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Number of employees: 565

Sales per Business

USD in Million2022Weight2023Weight Delta
Fertility Benefit Services
62.1 %
510 64.8 % 676 62.1 % +32.57%
Pharmacy Benefit Services
37.9 %
277 35.2 % 412 37.9 % +48.97%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
787 100.0 % 1,089 100.0 % +38.34%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 16-12-31
President 47 21-02-28
Director of Finance/CFO 58 19-04-30
Chairman 64 16-12-15
Chief Tech/Sci/R&D Officer - 23-04-03
Chief Tech/Sci/R&D Officer - 17-07-31
Investor Relations Contact - 19-06-30
General Counsel - 22-11-27
Corporate Officer/Principal - -
Human Resources Officer - 16-02-29

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 10-04-30
Director/Board Member 61 19-09-30
Director/Board Member 75 16-12-15
Director/Board Member 72 20-11-15
Director/Board Member 67 15-02-28
Director/Board Member 73 22-08-29
Director/Board Member 74 19-09-30
Director/Board Member 52 19-09-30
Chief Executive Officer 56 16-12-31
Chairman 64 16-12-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 96,726,259 83,488,270 ( 86.31 %) 615,980 ( 0.6368 %) 86.31 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
11.73 %
11,314,596 11.73 % 432 M $
Vanguard Fiduciary Trust Co.
8.570 %
8,270,153 8.570 % 316 M $
TPG Group Holdings (SBS) Advisors, Inc.
6.837 %
6,597,672 6.837 % 252 M $
Kleiner Perkins Caufield & Byers LLC
5.259 %
5,074,615 5.259 % 194 M $
ClearBridge Investments LLC
3.619 %
3,492,360 3.619 % 133 M $
JPMorgan Investment Management, Inc.
3.307 %
3,191,098 3.307 % 122 M $
Weatherbie Capital LLC
3.161 %
3,050,206 3.161 % 116 M $
2,785,370 2.886 % 106 M $
Jennison Associates LLC
2.621 %
2,528,790 2.621 % 96 M $
Thrivent Asset Management LLC
2.280 %
2,200,592 2.280 % 84 M $

Company contact information

Progyny, Inc.

1359 Broadway

10018, New York

+

http://www.progyny.com
address Progyny, Inc.(PGNY)

Sales per Business

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
32.5 USD
Average target price
46.9 USD
Spread / Average Target
+44.31%
Consensus